![]() “I have been privileged to lead the clinical development of gene therapy programs from inception through approval to deliver these transformative medicines to patients with life-threatening diseases. He completed a fellowship in infectious diseases at the Harvard Longwood Combined ID Program, his residency training in internal medicine, and an endocrinology research fellowship at the University of Chicago Hospitals. Davidson led clinical research for a wide range of therapeutic programs at Genzyme and GelTex, spanning biologics, polymers, and gene therapy. Davidson served as Chief Medical Officer of bluebird bio, where he played a critical role in advancing a broad genetic medicine pipeline across blood disorders, rare diseases and oncology, successfully leading numerous genetic medicine programs into the clinic and delivering multiple first-in-class approvals for genetic medicines in the U.S. Davidson brings over 20 years of expertise in clinical drug development focused on rare diseases and gene therapy to his new role as Tessera’s Chief Medical and Development Officer. “Together and alongside our current senior leadership team, they will be instrumental in advancing Tessera’s mission to bring forth innovative and curative medicines that go beyond the limitations of current technologies.”ĭr. Geoffrey von Maltzahn, CEO and Co-Founder of Tessera. “David, Hari and Lin all bring a wealth of strategic leadership and deep expertise to Tessera at an exciting time in our growth,” said Dr. The senior appointments come just two months after the company announced over $230 million in Series B fundraising in January and will be key to advancing the company’s Gene Writing platform and accelerating development of multiple therapeutic programs. as Senior Vice President of Rare Diseases Program Strategy and Operations. as Chief Operating Officer, and Lin Guey, Ph.D. as Chief Medical and Development Officer, Hari Pujar, Ph.D. CAMBRIDGE, Mass.-( BUSINESS WIRE)-Tessera Therapeutics, a biotech company pioneering Gene Writing, announced today the appointment of David Davidson, M.D. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |